Virohan Raises Rs. 14.9 crore in extended Series B Funding led by Blume Ventures
Healthcare edtech startup Virohan has recently secured Rs. 14.9 crore or $1.8 million in an extended pre-Series B round led by Blume Ventures. The Gurugram based company received such huge fund after a gap of 14 months.
A venture capital fund managed by MS&AD Ventures, Mitsui Sumitomo Insurance Venture Capital, also participated in the funding round along with Suneight OK Partnership (Suneight), Bharat Inclusive Technologies, GoldenBird MultiProduct LLP, VVAG Partners. Few individual investors also participated namely Pankaj Sharma, Sridhar Subramanian, Upasana Tilak Wadhwa, Viraj Nanda, Bhargav Suhas Jangle, and Vinita Bimbhet.
Lately, the managerial board in Virohan has passed a special resolution to issue 1,226 pre-Series B2 compulsory convertible preference shares (CCPS) at an issue price of Rs. 1,21,496 per share to raise Rs.14.9 crore or $1.8 million.
A prominent Venture Capitalist farm Blume ventures has bestowed Rs. 6.15 crore fund, while Mitsui Sumitomo Insurance Venture Capital and Suneight invested Rs. 4.08 crore and Rs. 2.48 crore, respectively.
As per the report of TheKredible, Virohan has been valued at around Rs. 425 crore or $51 million (post-money). This marks a significant 1.8X jump in the company’s valuation as compared to its previous fundraise.
The company was founded in 2018 by Archit Jayasal, Kunaal Dudeja, Nalin Saluja, and Parul Dudeja. Virohan offers healthcare vocational training to students to build a career in the healthcare industry. It conducts hybrid classrooms at over 20 campuses and online training across India in cities including Delhi, Gurgaon, Faridabad, Roorkee, Raipur, Mumbai, Nagpur, etc. Till the time, the company has extracted around $15 million from Rebright Partners, AngelList, and Elea Foundation among others.
Virohan’s profit scale upticked 63.8% during FY23 to Rs. 10.65 crore from Rs. 6.5 crore in FY22. On the contrary, the loss of the company increased 43.4% to Rs. 18.58 crore in FY23 as compared to Rs. 12.96 crore in FY22.
.jpg "Team Startupcity")
A venture capital fund managed by MS&AD Ventures, Mitsui Sumitomo Insurance Venture Capital, also participated in the funding round along with Suneight OK Partnership (Suneight), Bharat Inclusive Technologies, GoldenBird MultiProduct LLP, VVAG Partners. Few individual investors also participated namely Pankaj Sharma, Sridhar Subramanian, Upasana Tilak Wadhwa, Viraj Nanda, Bhargav Suhas Jangle, and Vinita Bimbhet.
Lately, the managerial board in Virohan has passed a special resolution to issue 1,226 pre-Series B2 compulsory convertible preference shares (CCPS) at an issue price of Rs. 1,21,496 per share to raise Rs.14.9 crore or $1.8 million.
A prominent Venture Capitalist farm Blume ventures has bestowed Rs. 6.15 crore fund, while Mitsui Sumitomo Insurance Venture Capital and Suneight invested Rs. 4.08 crore and Rs. 2.48 crore, respectively.
As per the report of TheKredible, Virohan has been valued at around Rs. 425 crore or $51 million (post-money). This marks a significant 1.8X jump in the company’s valuation as compared to its previous fundraise.
The company was founded in 2018 by Archit Jayasal, Kunaal Dudeja, Nalin Saluja, and Parul Dudeja. Virohan offers healthcare vocational training to students to build a career in the healthcare industry. It conducts hybrid classrooms at over 20 campuses and online training across India in cities including Delhi, Gurgaon, Faridabad, Roorkee, Raipur, Mumbai, Nagpur, etc. Till the time, the company has extracted around $15 million from Rebright Partners, AngelList, and Elea Foundation among others.
Virohan’s profit scale upticked 63.8% during FY23 to Rs. 10.65 crore from Rs. 6.5 crore in FY22. On the contrary, the loss of the company increased 43.4% to Rs. 18.58 crore in FY23 as compared to Rs. 12.96 crore in FY22.
